Published in J Neurochem on May 01, 2004
Treatment of Rett Syndrome With Recombinant Human IGF-1 | NCT01777542
Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci U S A (2009) 3.23
Brain-derived neurotrophic factor functions as a metabotrophin to mediate the effects of exercise on cognition. Eur J Neurosci (2008) 1.74
A simple role for BDNF in learning and memory? Front Mol Neurosci (2010) 1.68
Long-Term Mild, rather than Intense, Exercise Enhances Adult Hippocampal Neurogenesis and Greatly Changes the Transcriptomic Profile of the Hippocampus. PLoS One (2015) 1.67
Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax (2007) 1.61
Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS. Front Neuroendocrinol (2006) 1.40
Experimental models of Rett syndrome based on Mecp2 dysfunction. Exp Biol Med (Maywood) (2011) 1.27
β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A (2014) 1.23
Rett syndrome: genes, synapses, circuits, and therapeutics. Front Psychiatry (2012) 1.14
PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease. Dev Neurobiol (2008) 1.13
Acid-sensing ion channels: trafficking and synaptic function. Mol Brain (2013) 1.11
Regulation of hippocampal progenitor cell survival, proliferation and dendritic development by BDNF. Mol Neurodegener (2009) 1.10
Progesterone-estrogen interactions in synaptic plasticity and neuroprotection. Neuroscience (2012) 1.07
Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage. J Neurochem (2007) 1.04
Regional hippocampal differences in AKT survival signaling across the lifespan: implications for CA1 vulnerability with aging. Cell Death Differ (2008) 1.01
Ribosomal protein S3, a new substrate of Akt, serves as a signal mediator between neuronal apoptosis and DNA repair. J Biol Chem (2010) 1.00
Insulin-like growth factor-1 (IGF-1) induces the activation/phosphorylation of Akt kinase and cAMP response element-binding protein (CREB) by activating different signaling pathways in PC12 cells. BMC Neurosci (2006) 0.99
Interaction of FGF-2 with IGF-1 and BDNF in stimulating Akt, ERK, and neuronal survival in hippocampal cultures. Brain Res (2007) 0.98
Dendritic spine dysgenesis in Rett syndrome. Front Neuroanat (2014) 0.97
Cumulative activation of akt and consequent inhibition of glycogen synthase kinase-3 by brain-derived neurotrophic factor and insulin-like growth factor-1 in cultured hippocampal neurons. J Pharmacol Exp Ther (2005) 0.96
Neuroprotection signaling pathway of nerve growth factor and brain-derived neurotrophic factor against staurosporine induced apoptosis in hippocampal H19-7/IGF-IR [corrected]. Exp Mol Med (2010) 0.93
BDNF regulates the expression and distribution of vesicular glutamate transporters in cultured hippocampal neurons. PLoS One (2013) 0.91
Activation of the mammalian target of rapamycin complex 1 is both necessary and sufficient to stimulate eukaryotic initiation factor 2Bvarepsilon mRNA translation and protein synthesis. Int J Biochem Cell Biol (2008) 0.90
Constitutive hippocampal cholesterol loss underlies poor cognition in old rodents. EMBO Mol Med (2014) 0.87
Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta. PLoS One (2012) 0.86
Rett Syndrome: Reaching for Clinical Trials. Neurotherapeutics (2015) 0.85
Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness. Int J Nanomedicine (2015) 0.84
Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes. Front Cell Neurosci (2015) 0.84
Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders. J Child Psychol Psychiatry (2011) 0.84
Gene expression profiling of a hypoxic seizure model of epilepsy suggests a role for mTOR and Wnt signaling in epileptogenesis. PLoS One (2013) 0.82
Growth factor signaling and memory formation: temporal and spatial integration of a molecular network. Learn Mem (2013) 0.82
Programming of stress-related behavior and epigenetic neural gene regulation in mice offspring through maternal exposure to predator odor. Front Behav Neurosci (2015) 0.82
Yin and Yang of PDGF-mediated signaling pathway in the context of HIV infection and drug abuse. J Neuroimmune Pharmacol (2013) 0.81
Forkhead family transcription factor FoxO and neural differentiation. Neurogenetics (2012) 0.79
The role of Akt/FoxO3a in the protective effect of venlafaxine against corticosterone-induced cell death in PC12 cells. Psychopharmacology (Berl) (2013) 0.78
Activation of p38MAPK contributes to expanded polyglutamine-induced cytotoxicity. PLoS One (2008) 0.77
Wingless-type family member 3A triggers neuronal polarization via cross-activation of the insulin-like growth factor-1 receptor pathway. Front Cell Neurosci (2013) 0.77
Forkhead transcription factor FOXO3a levels are increased in Huntington disease because of overactivated positive autofeedback loop. J Biol Chem (2014) 0.77
Insulin-like growth factor 1 rescues R28 retinal neurons from apoptotic death through ERK-mediated BimEL phosphorylation independent of Akt. Exp Eye Res (2016) 0.76
The effect of recombinant human growth hormone therapy in patients with completed stroke: a pilot trial. Ann Rehabil Med (2012) 0.76
Hypoactivity affects IGF-1 level and PI3K/AKT signaling pathway in cerebral structures implied in motor control. PLoS One (2014) 0.76
Cell Signaling and Differential Protein Expression in Neuronal Differentiation of Bone Marrow Mesenchymal Stem Cells with Hypermethylated Salvador/Warts/Hippo (SWH) Pathway Genes. PLoS One (2015) 0.75
A Perspective on the Role of microRNA-128 Regulation in Mental and Behavioral Disorders. Front Cell Neurosci (2015) 0.75
SUN11602, a novel aniline compound, mimics the neuroprotective mechanisms of basic fibroblast growth factor. ACS Chem Neurosci (2012) 0.75
Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol (2002) 2.03
Psychosis pathways converge via D2high dopamine receptors. Synapse (2006) 1.78
The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev (2002) 1.41
Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol (2004) 1.35
Apoptosis-inducing factor: a matter of neuron life and death. Prog Neurobiol (2007) 1.31
A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration. Psychopharmacology (Berl) (2003) 1.23
Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse. J Neurosci (2010) 1.21
Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity. Eur J Neurosci (2006) 1.20
FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. J Neurochem (2002) 1.18
A microdialysis profile of Met-enkephalin release in the rat nucleus accumbens following alcohol administration. Alcohol Clin Exp Res (2005) 1.11
Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice. Behav Brain Res (2003) 1.09
Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci (2005) 1.09
Successful cognitive aging in rats: a role for mGluR5 glutamate receptors, homer 1 proteins and downstream signaling pathways. PLoS One (2012) 1.07
A microdialysis profile of dynorphin A(1-8) release in the rat nucleus accumbens following alcohol administration. Alcohol Clin Exp Res (2006) 1.04
The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology (2002) 1.04
Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opin Ther Targets (2007) 1.03
Estrogen effects on object memory and cholinergic receptors in young and old female mice. Neurobiol Aging (2001) 1.02
A possible role of neuropeptide Y in depression and stress. Brain Res (2009) 1.02
Long-lasting rescue of age-associated deficits in cognition and the CNS cholinergic phenotype by a partial agonist peptidomimetic ligand of TrkA. J Neurosci (2004) 1.01
Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. Eur J Pharmacol (2002) 0.99
Insulin-like growth factor-1 (IGF-1) induces the activation/phosphorylation of Akt kinase and cAMP response element-binding protein (CREB) by activating different signaling pathways in PC12 cells. BMC Neurosci (2006) 0.99
Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice. Neurobiol Dis (2009) 0.98
cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease. Pharmacol Ther (2003) 0.97
Does COX2-dependent PGE2 play a role in neuropathic pain? Neurosci Lett (2008) 0.96
Glutamate acting on N-methyl-D-aspartate receptors attenuates insulin-like growth factor-1 receptor tyrosine phosphorylation and its survival signaling properties in rat hippocampal neurons. J Biol Chem (2008) 0.95
Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells. Br J Pharmacol (2003) 0.95
Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing. J Mol Neurosci (2004) 0.95
α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling. J Neurochem (2011) 0.95
Neuropeptide Y (NPY) and depression: from animal studies to the human condition. Life Sci (2002) 0.95
Transthyretin: a key gene involved in the maintenance of memory capacities during aging. Neurobiol Aging (2007) 0.94
Protective action of resveratrol in human skin: possible involvement of specific receptor binding sites. PLoS One (2010) 0.92
Morphological reorganization after repeated corticosterone administration in the hippocampus, nucleus accumbens and amygdala in the rat. J Chem Neuroanat (2009) 0.92
Natural extracts as possible protective agents of brain aging. Neurobiol Aging (2002) 0.92
Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer's disease. Biomaterials (2010) 0.92
Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease. Eur J Neurosci (2013) 0.91
Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. J Pharmacol Exp Ther (2006) 0.90
Effect of Mas-related gene (Mrg) receptors on hyperalgesia in rats with CFA-induced inflammation via direct and indirect mechanisms. Br J Pharmacol (2013) 0.89
Insulin-like growth factor 1 prevents neuronal cell death induced by corticosterone through activation of the PI3k/Akt pathway. J Neurosci Res (2004) 0.89
Role of central calcitonin gene-related peptide (CGRP) in locomotor and anxiety- and depression-like behaviors in two mouse strains exhibiting a CGRP-dependent difference in thermal pain sensitivity. J Mol Neurosci (2009) 0.89
Hippocampal GABAergic neurons are susceptible to amyloid-β toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model. J Alzheimers Dis (2012) 0.88
Modulation of NMDA receptors by intrathecal administration of the sensory neuron-specific receptor agonist BAM8-22. Neuropharmacology (2007) 0.88
Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex. J Neurochem (2004) 0.87
Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.87
Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema. J Mol Neurosci (2007) 0.87
Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease. Neurobiol Aging (2006) 0.86
International perspectives on engaging the public in neuroethics. Nat Rev Neurosci (2005) 0.86
The involvement of spinal bovine adrenal medulla 22-like peptide, the proenkephalin derivative, in modulation of nociceptive processing. Eur J Neurosci (2007) 0.86
Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer disease. Am J Pathol (2010) 0.85
Group 1 metabotropic glutamate receptor function and its regulation of learning and memory in the aging brain. Front Pharmacol (2012) 0.85
Hippocampal gene expression profiling reveals the possible involvement of Homer1 and GABA(B) receptors in scopolamine-induced amnesia. J Neurochem (2007) 0.85
Reduction in acetylcholine release in the hippocampus of dopamine D5 receptor-deficient mice. Neuropsychopharmacology (2004) 0.84
Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions. J Neurochem (2004) 0.84
Heme oxygenase 1: another possible target to explain the neuroprotective action of resveratrol, a multifaceted nutrient-based molecule. Exp Neurol (2010) 0.84
Comparative neuroprotective properties of stilbene and catechin analogs: action via a plasma membrane receptor site? CNS Neurosci Ther (2009) 0.84
βCTF-correlated burst of hippocampal TNFα occurs at a very early, pre-plaque stage in the TgCRND8 mouse model of Alzheimer's disease. J Alzheimers Dis (2013) 0.84
Aged neuropeptide Y transgenic rats are resistant to acute stress but maintain spatial and non-spatial learning. Behav Brain Res (2004) 0.83
Amyloid beta peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology. Prog Brain Res (2004) 0.83
BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes. Br J Pharmacol (2005) 0.83
Estradiol valerate and alcohol intake: a comparison between Wistar and Lewis rats and the putative role of endorphins. Behav Brain Res (2003) 0.83
Signaling pathways relevant to cognition-enhancing drug targets. Handb Exp Pharmacol (2015) 0.82
Upregulation of adrenomedullin in the spinal cord and dorsal root ganglia in the early phase of CFA-induced inflammation in rats. Pain (2009) 0.82
Gene expression profiling following chronic NMDA receptor blockade-induced learning deficits in rats. Synapse (2003) 0.82
Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety. Neuropharmacology (2011) 0.82
Emotional behavior in aged neuropeptide Y (NPY) Y2 knockout mice. J Mol Neurosci (2006) 0.81
Systemic administration of kainic acid in adult rat stimulates expression of the chemokine receptor CCR5 in the forebrain. Glia (2002) 0.81
Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test. Peptides (2005) 0.81
Early environment contributes to developmental disruption of MPFC after neonatal ventral hippocampal lesions in rats. Synapse (2003) 0.81
Proteomic approaches in brain research and neuropharmacology. Eur J Pharmacol (2004) 0.81
Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8). Neurodegener Dis (2010) 0.81
Neuropeptide Y receptor subtypes in the dorsal vagal complex under acute feeding adaptation in the adult rat. Neuropeptides (2009) 0.81
Adrenomedullin-2/intermedin induces cAMP accumulation in dissociated rat spinal cord cells: evidence for the existence of a distinct class of sites of action. J Mol Neurosci (2008) 0.81
Targeting invading macrophage-derived PGE2, IL-6 and calcitonin gene-related peptide in injured nerve to treat neuropathic pain. Expert Opin Ther Targets (2006) 0.80
Neuroprotective effects of natural products: interaction with intracellular kinases, amyloid peptides and a possible role for transthyretin. Neurochem Res (2007) 0.80
Selective reduction in ventral hippocampal acetylcholine release in awake galanin-treated rats and galanin-overexpressing transgenic mice. Regul Pept (2004) 0.80
Adrenomedullin receptor binding sites in rat brain and peripheral tissues. Eur J Pharmacol (2003) 0.80
Morphological evidence for the involvement of microglial p38 activation in CGRP-associated development of morphine antinociceptive tolerance. Peptides (2010) 0.80
Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain. J Pharmacol Exp Ther (2005) 0.80
Loss of quinone reductase 2 function selectively facilitates learning behaviors. J Neurosci (2010) 0.80
An organelle proteomic method to study neurotransmission-related proteins, applied to a neurodevelopmental model of schizophrenia. Proteomics (2007) 0.79
An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization. EXS (2006) 0.79
Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation. BMC Neurosci (2006) 0.79
Possible role of dynorphins in Alzheimer's disease and age-related cognitive deficits. Neurodegener Dis (2013) 0.78
The expression of apoptosis inducing factor (AIF) is associated with aging-related cell death in the cortex but not in the hippocampus in the TgCRND8 mouse model of Alzheimer's disease. BMC Neurosci (2014) 0.78
Immune marker CD68 correlates with cognitive impairment in normally aged rats. Neurobiol Aging (2013) 0.78
Knockdown of prodynorphin gene prevents cognitive decline, reduces anxiety, and rescues loss of group 1 metabotropic glutamate receptor function in aging. J Neurosci (2013) 0.78
Aging and long-term caloric restriction regulate neuropeptide Y receptor subtype densities in the rat brain. Neuropeptides (2013) 0.77
Alterations in behavioral responses to a cholinergic agonist in post-pubertal rats with neonatal ventral hippocampal lesions: relationship to changes in muscarinic receptor levels. Neuropsychopharmacology (2005) 0.77
The common environmental pollutant dioxin-induced memory deficits by altering estrogen pathways and a major route of retinol transport involving transthyretin. Neurotoxicology (2008) 0.77
Inhibition of SNL-induced upregulation of CGRP and NPY in the spinal cord and dorsal root ganglia by the 5-HT(2A) receptor antagonist ketanserin in rats. Pharmacol Biochem Behav (2012) 0.77
Involvement of PKA-dependent upregulation of nNOS-CGRP in adrenomedullin-initiated mechanistic pathway underlying CFA-induced response in rats. Exp Neurol (2012) 0.76
Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP. Neuropeptides (2004) 0.76
Alzheimer disease: advances in pathogenesis, diagnosis, and therapy. Clin Chem (2011) 0.76
Blockade of adrenomedullin receptors reverses morphine tolerance and its neurochemical mechanisms. Behav Brain Res (2011) 0.76
Expression of apoptosis-inducing factor (AIF) in the aged rat brain. Neurobiol Aging (2009) 0.76
A role for protein kinase C-dependent upregulation of adrenomedullin in the development of morphine tolerance in male rats. J Neurosci (2010) 0.76
Clozapine administration reverses behavioral, neuronal, and nitric oxide disturbances in the neonatal ventral hippocampus rat. Neuropharmacology (2011) 0.76
Modulation of sensory neuron-specific receptors in the development of morphine tolerance and its neurochemical mechanisms. J Neurosci Res (2010) 0.75
Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY. Br J Pharmacol (2003) 0.75
Healing the healers. Healthc Q (2004) 0.75